Oct-Dec, 2011 - Indian Journal of Pharmacy Practice

More documents

Recommendations

Info

Satyanarayana V - Evaluation of the Impact of a Therapeutic Management and Effect of Pharmacist Intervention on Children with AsthmaModerate effectLarge effectVery Large effect0.50
Satyanarayana V - Evaluation of the Impact of a Therapeutic Management and Effect of Pharmacist Intervention on Children with Asthmathe mild intermittent category, 24% were in mild persistentand 10% were in moderate persistent category. Severepersistent cases had not been reported during the study period(Figure 2). Among infants, 20% have wheezing with onlyupper respiratory tract infections (URTIs), and 60% no longerhave wheezing by age 6 years. As Martinez et al have pointedout; however, many of these children are "transient wheezes"whose symptoms subside during the preschool or early school30, 31years . They tend to have no allergies, although their lungfunction is often abnormal. These findings have led to the ideathat they have small lungs.Fig. 2: Saverity of AsthmaSeverity of asthma is categorized based on the NAEPP(National Asthma Education and Prevention Programme) guidelinesIn the present study 50 prescriptions are analyzed before theintervention, and based in the data collected in the preintervention period an intervention strategy was designed inconsultation with clinical staff of the department. As a part ofintervention strategy interpersonal communication wasimproved, the seminars are arranged to detail on drug useproblems based on the pre intervention data. The clinical staffis impressed upon the need of improving where evernecessary to promote rational drug use and minimize drug useproblems. In post intervention period again 50 prescriptionsare examined and the full data are analyzed statistically.Number of drugs prescribed in the pre intervention study was330 and 283 in the post intervention study. Finding of theresult indicates there is no significant reduction in the numberof drugs prescribed. It has reported that average number ofdrugs prescribed per prescriptions is 6 in both pre interventionand post intervention studies. During pre intervention periodnumber of drugs prescribed in generics is 220 where as in postintervention period it is 227. However there is no significantin post intervention period. During pre intervention periodnumber of tablets prescribed is 110 reduced to 74 in postintervention period. (Table No 3 & Figure 3).We have observed that there is no significant improvement inthe number of nebulizers, cough syrups and oxygenTable 3: Prescription Analysis (I) by pre-intervention andpost-intervention dataPrescriptions Analysis Pre Postintervention interventionTotal number of prescriptions 50 50analysedTotal number of drugs prescribed 330 283Average number of drugs per 6 6prescriptionsNumber of drugs prescribed bed in 220 227genericsPercentage of drugs prescribed in 440 454genericsNumber of antibiotics prescribed 100 92Percentage of antibiotics prescribed 200 193Number of injections prescribed 110 74Percentage of tablet to prescribed 220 148Number of neublization prescribed 100 100Percentage of neublization prescribed 100 100Number of cough syrups prescribed 22 19Percentage of cough syrups prescribed 44 38Number of O2inhalation prescribed 50 50Percentage of O inhalation prescribed 100 1002Number of irrational prescribed 161 93Fig. 3: Prescription Analysis (I) by pre-intervention andpost-intervention dataprescribed between pre intervention and post interventionstudies. During pre intervention period number of irrationalprescribing reported was 161, but after intervention it wassignificantly reduced to 93. (Table No 4 & Figure 4).Naeti Suksomboon et al concluded that there was a significantdecreased in the number of drug related problems in the activeIndian Journal of Pharmacy Practice Volume 4 Issue 4 Oct - Dec, 2011 43
Page 1 and 2: Indian Journal of Pharmacy Practice
Page 3 and 4: Dear ReadersIndian Journal of Pharm
Page 5 and 6: Daxesh M P - Combating Antimicrobia
Page 13 and 14: J. Chang - India's Progress towards
Page 15 and 16: J. Chang - India's Progress towards
Page 17 and 18: Shobha C - Poison Information Cente
Page 25 and 26: Anantha Naik N -Health Related Qual
Page 33 and 34: Amrita P - Scenario of Pharmacovigi
Page 42 and 43: Satyanarayana V - Evaluation of the
Page 52 and 53: Dinesh KU - Evaluation of the Impac
Page 66 and 67: Pratham R - A Retrospective Study o
Page 70 and 71: Anoop P -Impact of Clinical Pharmac
Page 76 and 77: Singh B -Respiratory Tract Problems
Page 78 and 79: Singh B -Respiratory Tract Problems
Page 80 and 81: Mihir Y.P - Study of Prescribing Pa
Page 84 and 85: Ramanath K.V -Evaluation of the Imp
Page 86 and 87: Ramanath K.V -Evaluation of the Imp
Page 88 and 89: Instructions to AuthorsIntroduction
Page 90: Instructions to AuthorsElectronic j

Oct-Dec, 2011 - Indian Journal of Pharmacy Practice

Create successful ePaper yourself

Delete template?

Save as template?